Annual CFF
$67.46 M
-$80.43 M-54.38%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual cash flow from financing activities is $67.46 million, with the most recent change of -$80.43 million (-54.38%) on December 31, 2022.
- During the last 3 years, IMPL annual CFF has risen by +$67.44 million (+321142.86%).
Performance
IMPL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$7.06 M
+$7.05 M+141100.00%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly cash flow from financing activities is $7.06 million, with the most recent change of +$7.05 million (+141100.00%) on September 1, 2023.
- Over the past year, IMPL quarterly CFF has increased by +$2.33 million (+49.20%).
Performance
IMPL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$6.99 M
+$2.33 M+49.98%
September 1, 2023
Summary
- As of February 10, 2025, IMPL TTM cash flow from financing activities is $6.99 million, with the most recent change of +$2.33 million (+49.98%) on September 1, 2023.
- Over the past year, IMPL TTM CFF has dropped by -$60.81 million (-89.70%).
Performance
IMPL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMPL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.4% | +49.2% | -89.7% |
| 3 y3 years | +10000.0% | +578.2% | +554.7% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
IMPL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.4% | at low | -89.3% | -143.0% | -96.6% | -76.9% |
| 5 y | 5-year | -54.4% | -100.0% | -90.3% | -143.0% | -96.6% | -99.9% |
| alltime | all time | -54.4% | -100.0% | -90.3% | -143.0% | -96.6% | -99.9% |
Impel Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $7.06 M(>+9900.0%) | $6.99 M(+50.0%) |
| Jun 2023 | - | $5000.00(>+9900.0%) | $4.66 M(+188.1%) |
| Mar 2023 | - | $0.00(-100.0%) | $1.62 M(-97.6%) |
| Dec 2022 | $67.46 M(-54.4%) | -$79.00 K(-101.7%) | $67.46 M(-0.5%) |
| Sep 2022 | - | $4.73 M(-255.9%) | $67.80 M(-48.2%) |
| Jun 2022 | - | -$3.04 M(-104.6%) | $130.78 M(-36.6%) |
| Mar 2022 | - | $65.84 M(>+9900.0%) | $206.42 M(+39.6%) |
| Dec 2021 | $147.89 M | $261.00 K(-99.6%) | $147.89 M(-6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $67.72 M(-6.7%) | $157.62 M(+73.3%) |
| Jun 2021 | - | $72.60 M(+893.4%) | $90.95 M(+395.3%) |
| Mar 2021 | - | $7.31 M(-26.9%) | $18.36 M(+66.0%) |
| Dec 2020 | $11.06 M(>+9900.0%) | $9.99 M(+859.8%) | $11.06 M(+936.5%) |
| Sep 2020 | - | $1.04 M(+5683.3%) | $1.07 M(+4003.8%) |
| Jun 2020 | - | $18.00 K(+125.0%) | $26.00 K(+225.0%) |
| Mar 2020 | - | $8000.00 | $8000.00 |
| Dec 2019 | $21.00 K | - | - |
FAQ
- What is Impel Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual CFF year-on-year change?
- What is Impel Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly CFF year-on-year change?
- What is Impel Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals TTM CFF year-on-year change?
What is Impel Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of IMPL is $67.46 M
What is the all time high annual CFF for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual cash flow from financing activities is $147.89 M
What is Impel Pharmaceuticals annual CFF year-on-year change?
Over the past year, IMPL annual cash flow from financing activities has changed by -$80.43 M (-54.38%)
What is Impel Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of IMPL is $7.06 M
What is the all time high quarterly CFF for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly cash flow from financing activities is $72.60 M
What is Impel Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, IMPL quarterly cash flow from financing activities has changed by +$2.33 M (+49.20%)
What is Impel Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of IMPL is $6.99 M
What is the all time high TTM CFF for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high TTM cash flow from financing activities is $206.42 M
What is Impel Pharmaceuticals TTM CFF year-on-year change?
Over the past year, IMPL TTM cash flow from financing activities has changed by -$60.81 M (-89.70%)